Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

No studies found 1 · 14.3%GRADE not reported 0 · 0%Very low 1 · 14.3%Low 4 · 57.1%Moderate 1 · 14.3%High 0 · 0%

All‐cause mortality · patients with stable angina pectoris

Ranolazine (monotherapy) showed no clear difference in all‐cause mortality compared with placebo (low certainty).

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
RR 1 [0.81, 1.25]
3 studies · 6249 participants
Low

Quality of life Scale: 0 to 100 · patients with stable angina pectoris

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 2256 participants
Moderate

AMI incidence · patients with stable angina pectoris

Ranolazine (monotherapy) showed no clear difference in AMI incidence compared with placebo (low certainty).

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
RR 0.88 [0.69, 1.12]
3 studies · 2983 participants
Low

Angina episodes frequency · patients with stable angina pectoris

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 402 participants
Low

Adverse events incidence · patients with stable angina pectoris

It is very uncertain whether ranolazine (monotherapy) changes adverse events incidence compared with placebo (very low certainty).

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
RR 1.5 [1.12, 2]
3 studies · 947 participants
Very low

Cardiovascular mortality · patients with stable angina pectoris

Ranolazine (monotherapy) showed no clear difference in cardiovascular mortality compared with placebo (low certainty).

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
RR 1.03 [0.56, 1.88]
1 study · 2604 participants
Low

Non‐cardiovascular mortality ‐ not reported · patients with stable angina pectoris

The review found no eligible studies for this question.

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found